TF and Portal vein thrombosis: Examples of its application in the clinical setting are the detection of risk factors for portal vein thrombosis due to endothelial damage and EV release [26], diffuse intravascular coagulation (DIC) [27], and also previous preclinical experiments assessing EV-bound TF released from endothelial cells [21].